Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Toll-like receptor 4 polymorphisms and risk of gram-negative bacteremia after allogeneic stem cell transplantation. A prospective pilot study.

Mensah NY, Peterlongo P, Steinherz P, Pamer EG, Satagopan J, Papanicolaou GA.

Biol Blood Marrow Transplant. 2009 Sep;15(9):1130-3. doi: 10.1016/j.bbmt.2009.04.012. Epub 2009 Jun 26. Erratum in: Biol Blood Marrow Transplant. 2010 Jan;16(1):128. Yaa, Mensah Nana [corrected to Mensah, Nana Yaa]; Paolo, Peterlongo [corrected to Peterlongo, Paolo]; Peter, Steinherz [corrected to Steinherz, Peter]; Eric, Pamer G [corrected to Pamer, Eric G]; Jaya, Satagopan [corrected to Satagopan, Jaya].

2.

P2X7 receptor polymorphism and clinical outcomes in HLA-matched sibling allogeneic hematopoietic stem cell transplantation.

Lee KH, Park SS, Kim I, Kim JH, Ra EK, Yoon SS, Hong YC, Park S, Kim BK.

Haematologica. 2007 May;92(5):651-7.

3.

Polymorphisms in Toll-like receptor genes and susceptibility to infections in allogeneic stem cell transplantation.

Carvalho A, Cunha C, Carotti A, Aloisi T, Guarrera O, Di Ianni M, Falzetti F, Bistoni F, Aversa F, Pitzurra L, Rodrigues F, Romani L.

Exp Hematol. 2009 Sep;37(9):1022-9. doi: 10.1016/j.exphem.2009.06.004. Epub 2009 Jun 17.

PMID:
19539691
4.

Toll-like 4 receptor variant, Asp299Gly, and reduced risk of hemorrhagic cystitis after hematopoietic stem cell transplantation.

Gruhn B, Klöppner N, Pfaffendorf-Regler N, Beck J, Zintl F, Bartholomä S, Debatin KM, Steinbach D.

Biol Blood Marrow Transplant. 2012 Jun;18(6):958-63. doi: 10.1016/j.bbmt.2012.01.018. Epub 2012 Jan 30.

5.

Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections.

Agnese DM, Calvano JE, Hahm SJ, Coyle SM, Corbett SA, Calvano SE, Lowry SF.

J Infect Dis. 2002 Nov 15;186(10):1522-5. Epub 2002 Oct 29.

PMID:
12404174
6.
7.

Mannose-binding lectin gene polymorphisms are associated with major infection following allogeneic hemopoietic stem cell transplantation.

Mullighan CG, Heatley S, Doherty K, Szabo F, Grigg A, Hughes TP, Schwarer AP, Szer J, Tait BD, Bik To L, Bardy PG.

Blood. 2002 May 15;99(10):3524-9.

8.

Toll-like receptor 4 Asp299Gly/Thr399Ile polymorphisms are a risk factor for Candida bloodstream infection.

Van der Graaf CA, Netea MG, Morré SA, Den Heijer M, Verweij PE, Van der Meer JW, Kullberg BJ.

Eur Cytokine Netw. 2006 Mar;17(1):29-34.

9.

Toll-like receptor 4 gene polymorphisms and preeclampsia: lack of association in a Caucasian population.

Molvarec A, Jermendy A, Kovács M, Prohászka Z, Rigó J Jr.

Hypertens Res. 2008 May;31(5):859-64. doi: 10.1291/hypres.31.859.

PMID:
18712040
10.

Toll-like receptor 4 polymorphisms and the risk of gram-negative bacterial infections after liver transplantation.

Lee SO, Brown RA, Kang SH, Abdel Massih RC, Razonable RR.

Transplantation. 2011 Sep 27;92(6):690-6. doi: 10.1097/TP.0b013e31822b589f.

PMID:
21822168
11.

TLR4 mutations (Asp299Gly and Thr399Ile) are not associated with ankylosing spondylitis.

Adam R, Sturrock RD, Gracie JA.

Ann Rheum Dis. 2006 Aug;65(8):1099-101.

12.

Analysis of single nucleotide polymorphisms in Toll-like receptor 4 shows no association with ankylosing spondylitis in a Korean population.

Na KS, Kim TH, Rahman P, Peddle L, Choi CB, Inman RD.

Rheumatol Int. 2008 May;28(7):627-30. Epub 2007 Nov 22.

PMID:
18034244
13.
14.

TLR1 and TLR6 polymorphisms are associated with susceptibility to invasive aspergillosis after allogeneic stem cell transplantation.

Kesh S, Mensah NY, Peterlongo P, Jaffe D, Hsu K, VAN DEN Brink M, O'reilly R, Pamer E, Satagopan J, Papanicolaou GA.

Ann N Y Acad Sci. 2005 Dec;1062:95-103.

PMID:
16461792
15.

Identification of polymorphisms in the Toll-like receptor gene and the association with allergic rhinitis.

Kang I, Oh YK, Lee SH, Jung HM, Chae SC, Lee JH.

Eur Arch Otorhinolaryngol. 2010 Mar;267(3):385-9. doi: 10.1007/s00405-009-1100-y. Epub 2009 Sep 18.

PMID:
19763595
16.

Functional consequences of toll-like receptor 4 polymorphisms.

Ferwerda B, McCall MB, Verheijen K, Kullberg BJ, van der Ven AJ, Van der Meer JW, Netea MG.

Mol Med. 2008 May-Jun;14(5-6):346-52. doi: 10.2119/2007-00135.Ferwerda. Review.

17.

Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock.

Lorenz E, Mira JP, Frees KL, Schwartz DA.

Arch Intern Med. 2002 May 13;162(9):1028-32.

PMID:
11996613
18.

The role of Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms and CARD15/NOD2 mutations in the susceptibility and phenotype of Crohn's disease.

Brand S, Staudinger T, Schnitzler F, Pfennig S, Hofbauer K, Dambacher J, Seiderer J, Tillack C, Konrad A, Crispin A, Göke B, Lohse P, Ochsenkühn T.

Inflamm Bowel Dis. 2005 Jul;11(7):645-52.

PMID:
15973118
19.

Association of TLR4 mutations and the risk for acute GVHD after HLA-matched-sibling hematopoietic stem cell transplantation.

Lorenz E, Schwartz DA, Martin PJ, Gooley T, Lin MT, Chien JW, Hansen JA, Clark JG.

Biol Blood Marrow Transplant. 2001;7(7):384-7.

PMID:
11529488
20.

Blood stream infections in allogeneic hematopoietic stem cell transplant recipients: reemergence of Gram-negative rods and increasing antibiotic resistance.

Mikulska M, Del Bono V, Raiola AM, Bruno B, Gualandi F, Occhini D, di Grazia C, Frassoni F, Bacigalupo A, Viscoli C.

Biol Blood Marrow Transplant. 2009 Jan;15(1):47-53. doi: 10.1016/j.bbmt.2008.10.024.

Supplemental Content

Support Center